Skip To Main Content
Určeno pro odbornou veřejnost
Campus
Campus
View Full Results

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
EASD 2025 Kongresinden Öne Çıkan Noktalar: İglarLiksi

EASD 2025 Kongresinden Öne Çıkan Noktalar: İglarLiksi

Číst více
EASD 2025 Kongresinden Öne Çıkan Noktalar: Glarjin U300

EASD 2025 Kongresinden Öne Çıkan Noktalar: Glarjin U300

Číst více
Sleep and QOL: the full impact on patients coping with the burden of AD

Sleep and QOL: the full impact on patients coping with the burden of AD

Understanding the full scope of AD—the unseen burden on patients.

Číst více
Sleep and QOL: the full impact on patients coping with the burden of AD

Sleep and QOL: the full impact on patients coping with the burden of AD

Understanding the full scope of AD—the unseen burden on patients.

Číst více
Sleep and QOL: the full impact on patients coping with the burden of AD

Sleep and QOL: the full impact on patients coping with the burden of AD

Understanding the full scope of AD—the unseen burden on patients.

Číst více
Sleep and QOL: the full impact on patients coping with the burden of AD

Sleep and QOL: the full impact on patients coping with the burden of AD

Understanding the full scope of AD—the unseen burden on patients.

Číst více
Sleep and QOL: the full impact on patients coping with the burden of AD

Sleep and QOL: the full impact on patients coping with the burden of AD

Understanding the full scope of AD—the unseen burden on patients.

Číst více
Conoce el consenso médico sobre las vacunas hexavalentes acelulares (aP)

Conoce el consenso médico sobre las vacunas hexavalentes acelulares (aP)

Conoce el consenso en vacunación, cobertura y beneficios sobre las vacunas hexavalentes acelulares (aP). Destaca la reducción del 67% en eventos adversos, evidencia del mundo real y desafíos en aceptación. Este es el enfoque en su contribución a la salud pública.​

Číst více
To Be a Detective: Finding Gaucher Patients <br> Hint 2: How to Differentiate Gaucher Disease Type 1 VS Type 3 And the Likelihood of Symptoms Occurring

To Be a Detective: Finding Gaucher Patients
Hint 2: How to Differentiate Gaucher Disease Type 1 VS Type 3 And the Likelihood of Symptoms Occurring

Číst více
To Be a Detective: Finding Gaucher Patients <br> Hint 2: How to Differentiate Gaucher Disease Type 1 VS Type 3 And the Likelihood of Symptoms Occurring

To Be a Detective: Finding Gaucher Patients
Hint 2: How to Differentiate Gaucher Disease Type 1 VS Type 3 And the Likelihood of Symptoms Occurring

Číst více
Descifrando la inflamación de tipo 2 en la EPOC: la perspectiva de un experto

Descifrando la inflamación de tipo 2 en la EPOC: la perspectiva de un experto

Autor: Equipo editorial de Sanofi

Equipo editorial de Sanofi 

 

Comprender la inflamación de tipo 2 es la clave para controlar los síntomas y las exacerbaciones de la EPOC. 

Číst více
Inflamación de tipo 2 en la EPOC

Inflamación de tipo 2 en la EPOC

Číst více